Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LUMENHANCE

MANGANESE CHLORIDE TETRAHYDRATE

Standard Dose
3.49MG/GM
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview LUMENHANCE is listed in Drugs@FDA under application 020686 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MANGANESE CHLORIDE TETRAHYDRATE Form and strength FOR SOLUTION;ORAL - 3.49MG/GM Sponsor BRACCO Submission history Latest submission status date: 1997-12-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview LUMENHANCE is listed in Drugs@FDA under application 020686 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MANGANESE CHLORIDE TETRAHYDRATE Form and strength FOR SOLUTION;ORAL - 3.49MG/GM Sponsor BRACCO Submission history Latest submission status date: 1997-12-19 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.